This is an old revision of the document!


Objectives

Determine biomarkers for Alzheimer's and other neurodegenerative diseases using comprehensive analysis of various data including genomics, epigenomics, metabolomics, proteomics, etc.

Data

  1. Large cohorts with phenotype data on dementia are available through the Cohorts for Heart and Aging Research in Genomic Epidemiology (CHARGE) Consortium and The Trans-Omics for Precision Medicine (TOPMed) program

Collaborators

Dr. Sudha Seshadri, the Founding Director of The Glenn Biggs Institute for Alzheimer's & Neurodegenerative Diseases.

Subprojects